{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:28:29Z","timestamp":1790188109232,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T00:00:00Z","timestamp":1581552000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T00:00:00Z","timestamp":1581552000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1208\/s12249-019-1616-4","type":"journal-article","created":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T14:03:57Z","timestamp":1581689037000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Fabrication of Fine Puerarin Nanocrystals by Box\u2013Behnken Design to Enhance Intestinal Absorption"],"prefix":"10.1208","volume":"21","author":[{"given":"Meng","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangying","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiali","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6896-3661","authenticated-orcid":false,"given":"Liangxing","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,13]]},"reference":[{"issue":"9","key":"1616_CR1","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.jnutbio.2011.05.015","volume":"23","author":"R Chen","year":"2012","unstructured":"Chen R, Xue J, Xie ML. Puerarin prevents isoprenaline-induced myocardial fibrosis in mice by reduction of myocardial TGF-\u03b21 expression. J Nutr Biochem. 2012;23(9):1080\u20135.","journal-title":"J Nutr Biochem"},{"issue":"4","key":"1616_CR2","first-page":"293","volume":"13","author":"XH Chen","year":"2010","unstructured":"Chen XH, Tian DQ, Wei LR. Literature analysis of adverse reactions induced by puerarin injection. Practical Pharmacy and Clinical Remedies. 2010;13(4):293\u20135.","journal-title":"Practical Pharmacy and Clinical Remedies"},{"issue":"3","key":"1616_CR3","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jconrel.2012.03.013","volume":"160","author":"L Gao","year":"2012","unstructured":"Gao L, Liu GY, Ma JL, Wang XQ, Zhou L, Li X. Drug nanocrystals: in vivo performances. J Control Release. 2012;160(3):418\u201330.","journal-title":"J Control Release"},{"issue":"2","key":"1616_CR4","first-page":"124","volume":"24","author":"CM Keck","year":"2008","unstructured":"Keck CM, Kobierski S, Mauludin R, M\u00fcller RH. Second generation of drug nanocrystals for delivery of poorly soluble drugs: smartcrystals technology. Dosis. 2008;24(2):124\u20138.","journal-title":"Dosis."},{"issue":"16","key":"1616_CR5","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.2217\/nnm.15.73","volume":"10","author":"Y Lu","year":"2015","unstructured":"Lu Y, Chen Y, Gemeinhart RA, Wu W, Li T. Developing nanocrystals for cancer treatment. Nanomedicine-UK. 2015;10(16):2537\u201352.","journal-title":"Nanomedicine-UK"},{"key":"1616_CR6","doi-asserted-by":"crossref","unstructured":"Lu Y, Li Y, Wu W. 2016. Injected nanocrystals for targeted drug delivery. Acta Pharm Sin B 2016;6(2):106\u2013113.","DOI":"10.1016\/j.apsb.2015.11.005"},{"issue":"2","key":"1616_CR7","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.coche.2011.12.001","volume":"1","author":"GD Wang","year":"2012","unstructured":"Wang GD, Mallet FP, Ricard F, Heng JYY. Pharmaceutical nanocrystals. Curr Opin Chem Eng. 2012;1(2):102\u20137.","journal-title":"Curr Opin Chem Eng"},{"issue":"6","key":"1616_CR8","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1208\/s12249-015-0461-3","volume":"17","author":"PF Yue","year":"2016","unstructured":"Yue PF, Xiao MS, Xie YB, Ma YM, Guan YM, Wu ZF, et al. The roles of vitrification of stabilizers\/matrix formers for the redispersibility of drug nanocrystals after solidification: a case study. AAPS PharmSciTech. 2016;17(6):1274\u201384.","journal-title":"AAPS PharmSciTech"},{"issue":"9","key":"1616_CR9","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3390\/molecules21091149","volume":"21","author":"YB Xie","year":"2016","unstructured":"Xie YB, Ma YQ, Xu JN, Liu Y, Yue PF, Zheng Q, et al. Panax notoginseng saponins as a novel nature stabilizer for poorly soluble drug nanocrystals: a case study with baicalein. Molecules. 2016;21(9):1149.","journal-title":"Molecules."},{"issue":"3","key":"1616_CR10","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.drudis.2018.01.016","volume":"23","author":"M Malamatari","year":"2018","unstructured":"Malamatari M, Taylor KMG, Malamataris S, Douroumis D, Kachrimanis K. Pharmaceutical nanocrystals: production by wet milling and applications. Drug Discov Today. 2018;23(3):534\u201347.","journal-title":"Drug Discov Today"},{"issue":"2","key":"1616_CR11","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ijpharm.2017.02.065","volume":"533","author":"F Toziopoulou","year":"2017","unstructured":"Toziopoulou F, Malamatari M, Nikolakakisa I, Kachrimanis K. Production of aprepitant nanocrystals by wet media milling and subsequent solidification. Int J Pharm. 2017;533(2):324\u201334.","journal-title":"Int J Pharm"},{"issue":"5","key":"1616_CR12","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s11051-008-9357-4","volume":"10","author":"L Gao","year":"2008","unstructured":"Gao L, Zhang DR, Chen MH. Drug nanocrystals for the formulation of poorly soluble drugs and its application as a potential drug delivery system. J Nanopart Res. 2008;10(5):845\u201362.","journal-title":"J Nanopart Res"},{"issue":"1","key":"1616_CR13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejpb.2005.05.009","volume":"62","author":"CM Keck","year":"2006","unstructured":"Keck CM, M\u00fcller RH. Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. Eur J Pharm Biopharm. 2006;62(1):3\u201316.","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"1616_CR14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijpharm.2013.10.001","volume":"458","author":"LX Tu","year":"2013","unstructured":"Tu LX, Yi YN, Wu W, Hu FQ, Hu KL, Feng JF. Effects of particle size on the pharmacokinetics of puerarin nanocrystals and microcrystals after oral administration to rat. Int J Pharm. 2013;458(1):135\u201340.","journal-title":"Int J Pharm"},{"issue":"1","key":"1616_CR15","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.colsurfb.2015.04.054","volume":"133","author":"YN Yi","year":"2015","unstructured":"Yi YN, Tu LX, Hu KL, Wu W, Feng JF. The construction of puerarin nanocrystals and its pharmacokinetic and in vivo\u2013in vitro correlation (IVIVC) studies on beagle dog. Colloid Suface B. 2015;133(1):164\u201370.","journal-title":"Colloid Suface B"},{"issue":"2","key":"1616_CR16","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2217\/nnm.09.110","volume":"5","author":"E Roger","year":"2010","unstructured":"Roger E, Lagarce F, Garcion E, Benoit JP. Biopharmaceutical parameters to consider in order to alter the fate of nanocarriers after oral delivery. Nanomedicine-UK. 2010;5(2):287\u2013306.","journal-title":"Nanomedicine-UK."},{"issue":"6","key":"1616_CR17","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.ajps.2017.10.004","volume":"13","author":"Q Yu","year":"2018","unstructured":"Yu Q, Wu XY, Zhu QG, Wu W, Chen ZJ, Li Y, et al. Enhanced transdermal delivery of meloxicam by nanocrystals: preparation, in vitro and in vivo evaluation. Asian J Pharm Sci. 2018;13(6):518\u201326.","journal-title":"Asian J Pharm Sci"},{"issue":"28","key":"1616_CR18","first-page":"65","volume":"270","author":"YK Xie","year":"2017","unstructured":"Xie YK, Shi BK, Xia F, Qi JP, Dong XC, Zhao WL, et al. Epithelia transmembrane transport of orally administered ultrafine drug particles evidenced by environment sensitive fluorophores in cellular and animal studies. J Control Release. 2017;270(28):65\u201375.","journal-title":"J Control Release"},{"issue":"4","key":"1616_CR19","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.drudis.2017.01.003","volume":"22","author":"Y Lu","year":"2017","unstructured":"Lu Y, Qi JP, Dong XC, Zhao WL, Wu W. The in vivo fate of nanocrystals. Drug Discov Today. 2017;22(4):744\u201350.","journal-title":"Drug Discov Today"},{"key":"1616_CR20","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.2147\/IJN.S164228","volume":"13","author":"YQ Ma","year":"2018","unstructured":"Ma YQ, Yang Y, Xie J, Yue PF, Yang M. Novel nanocrystal-based solid dispersion with high drug loading, enhanced dissolution, and bioavailability of andrographolide. Int J Nanomedicine. 2018;13:3763\u201379.","journal-title":"Int J Nanomedicine"},{"key":"1616_CR21","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ijbiomac.2016.02.033","volume":"87","author":"MA Kalam","year":"2016","unstructured":"Kalam MA, Khan AA, Khan S, Almalik A, Alshamsan A. Optimizing indomethacin-loaded chitosan nanoparticle size encapsulation, and release using Box\u2013Behnken experimental design. Int J Biol Macromol. 2016;87:329\u201340.","journal-title":"Int J Biol Macromol"},{"key":"1616_CR22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10953-007-9217-3","volume":"37","author":"J Xi","year":"2008","unstructured":"Xi J, Guo R. Interactions of puerarin with micelles: pKa shifts and thermodynamics. J Solut Chem. 2008;37:107\u201318.","journal-title":"J Solut Chem"},{"issue":"1","key":"1616_CR23","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jep.2012.04.027","volume":"142","author":"CL Sa","year":"2012","unstructured":"Sa CL, Lv H, Ba YY, Sun JN, Shi RB. The effects of notoginsenoside R1 on the intestinal absorption of geniposide by the everted rat gut sac model. J Ethnopharmacol. 2012;142(1):136\u201343.","journal-title":"J Ethnopharmacol"},{"issue":"2","key":"1616_CR24","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4103\/2231-4040.154542","volume":"6","author":"AK Vora","year":"2015","unstructured":"Vora AK, Londhe VY, Pandita NS. Preparation and characterization of standardized pomegranate extract-phospholipid complex as an effective drug delivery tool. J Adv Pharm Technol Res. 2015;6(2):75\u201380.","journal-title":"J Adv Pharm Technol Res"},{"key":"1616_CR25","doi-asserted-by":"crossref","first-page":"43372","DOI":"10.1038\/srep43372","volume":"7","author":"HL Liu","year":"2017","unstructured":"Liu HL, Tu LX, Zhou YX, Dang ZF, Wang LT, Du JF, et al. Improved bioavailability and antitumor effect of docetaxel by TPGS modified proniosomes: in vitro and in vivo evaluations. Sci Rep-UK. 2017;7:43372.","journal-title":"Sci Rep-UK"},{"issue":"15","key":"1616_CR26","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jpba.2018.12.018","volume":"167","author":"A Tambe","year":"2019","unstructured":"Tambe A, Mokashi P, Pandita N. Ex-vivo intestinal absorption study of boswellic acid, cyclodextrin complexes and poloxamer solid dispersions using everted gut sac technique. J Pharmaceut Biomed. 2019;167(15):66\u201373.","journal-title":"J Pharmaceut Biomed"},{"key":"1616_CR27","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejpb.2018.06.022","volume":"130","author":"S Huang","year":"2018","unstructured":"Huang S, Zhang Q, Li H, Sun YQ, Cheng G, Zou MJ, et al. Increased bioavailability of efonidipine hydrochloride nanosuspensions by the wet-milling method. Eur J Pharm Biopharm. 2018;130:108\u201314.","journal-title":"Eur J Pharm Biopharm"},{"issue":"2\u20133","key":"1616_CR28","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ejps.2008.10.013","volume":"36","author":"A Dahan","year":"2009","unstructured":"Dahan A, West BT, Amidon GL. Segmental-dependent membrane permeability along the intestine following oral drug administration: evaluation of a triple single-pass intestinal perfusion (TSPIP) approach in the rat. Eur J Pharm Sci. 2009;36(2\u20133):320\u20139.","journal-title":"Eur J Pharm Sci"},{"issue":"3","key":"1616_CR29","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jconrel.2008.10.002","volume":"133","author":"HL Li","year":"2009","unstructured":"Li HL, Zhao XB, Ma YK, Zhai GX, Li LB, Lou HX. Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles. J Control Release. 2009;133(3):238\u201344.","journal-title":"J Control Release"},{"issue":"1","key":"1616_CR30","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3109\/03639045.2012.746362","volume":"40","author":"VP Greeshma","year":"2014","unstructured":"Greeshma VP, Vaibhav BP, Abhishek P, Sadhana JR. Nanosuspension of efavirenz for improved oral bioavailability: formulation optimization, in vitro, in situ and in vivo evaluation. Drug Dev Ind Pharm. 2014;40(1):80\u201391.","journal-title":"Drug Dev Ind Pharm"},{"issue":"3","key":"1616_CR31","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejps.2011.04.011","volume":"43","author":"MH Sun","year":"2011","unstructured":"Sun MH, Zhai XZ, Xue KW, Hu L, Yang XL, Li G, et al. Intestinal absorption and intestinal lymphatic transport of sirolimus from self-microemulsifying drug delivery systems assessed using the single-pass intestinal perfusion (SPIP) technique and a chylomicron flow blocking approach: linear correlation with oral bioavailabilities in rats. Eur J Pharm Sci. 2011;43(3):132\u201340.","journal-title":"Eur J Pharm Sci"},{"issue":"9","key":"1616_CR32","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1002\/jps.24258","volume":"104","author":"D Dahlgeren","year":"2015","unstructured":"Dahlgeren D, Roos C, Sj\u014fgren E, Lennern\u0103s H. Direct in vivo human intestinal permeability (Peff) determined with different clinical perfusion and intubation methods. J Pharm Sci-US. 2015;104(9):2702\u201326.","journal-title":"J Pharm Sci-US"},{"issue":"8","key":"1616_CR33","first-page":"1838","volume":"46","author":"Y Mohd","year":"2018","unstructured":"Mohd Y, Udai VSS, Iti C, Praveen KG, Alok PS, Dinesh P, et al. Solid lipid nanoparticles for nose to brain delivery of donepezil: formulation, optimization by Box-Behnken design, in vitro and in vivo evaluation. Artif Cell Nanomed B. 2018;46(8):1838\u201351.","journal-title":"Artif Cell Nanomed B"},{"key":"1616_CR34","first-page":"683","volume":"6","author":"JF Hao","year":"2011","unstructured":"Hao JF, Fang XS, Zhou YF, Wang JZ, Guo FG, Li F, et al. Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box-Behnken design. Int J Nanomedicine. 2011;6:683\u201392.","journal-title":"Int J Nanomedicine"},{"key":"1616_CR35","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jddst.2017.12.014","volume":"44","author":"S Kumar","year":"2018","unstructured":"Kumar S, Narayan R, Ahammed V, Nayak Y, Naha A, Nayak UY. Development of ritonavir solid lipid nanoparticles by Box Behnken design for intestinal lymphatic targeting. J Drug Deliv Sci Tec. 2018;44:181\u20139.","journal-title":"J Drug Deliv Sci Tec"},{"issue":"2","key":"1616_CR36","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0378-5173(97)00311-6","volume":"160","author":"RH M\u00fcller","year":"1998","unstructured":"M\u00fcller RH, Peters K. Nanosuspensions for the formulation of poorly soluble drugs: preparation by a size-reduction technique. Int J Pharm. 1998;160(2):229\u201337.","journal-title":"Int J Pharm"},{"key":"1616_CR37","doi-asserted-by":"crossref","first-page":"118465","DOI":"10.1016\/j.ijpharm.2019.118465","volume":"567","author":"PJ Skrdla","year":"2019","unstructured":"Skrdla PJ, Floyd PD, Dell\u2019Orco PC. Predicting the solubility enhancement of amorphous drugs and related phenomena using basic thermodynamic principles and semi-empirical kinetic models. Int J Pharm. 2019;567:118465.","journal-title":"Int J Pharm"},{"key":"1616_CR38","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.ejpb.2008.01.023","volume":"69","author":"F Ya\u0148ez","year":"2008","unstructured":"Ya\u0148ez F, Concheiro A, Alvarez-Lorenzo C. Macromolecule release and smoothness of semi-interpenetrating PVP\u2013pHEMA networks for comfortable soft contact lenses. Eur J Pharm Biopharm. 2008;69:1094\u201303.","journal-title":"Eur J Pharm Biopharm"},{"issue":"10","key":"1616_CR39","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1080\/00498254.2018.1518552","volume":"49","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, Song X, Dong G. Effects of verapamil on the pharmacokinetics of puerarin in rats. Xenobiotica. 2018;49(10):1178\u201382.","journal-title":"Xenobiotica."},{"issue":"1","key":"1616_CR40","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1080\/10717544.2016.1259372","volume":"24","author":"T Yi","year":"2017","unstructured":"Yi T, Tang DD, Wang F, Zhang JQ, Zhang J, Wang JR, et al. Enhancing both oral bioavailability and brain penetration of puerarin using borneol in combination with preparation technologies. Drug Deliv. 2017;24(1):422\u20139.","journal-title":"Drug Deliv"},{"issue":"3","key":"1616_CR41","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1124\/dmd.105.007757","volume":"34","author":"M Ballent","year":"2006","unstructured":"Ballent M, Lifschitz A, Virkel G, Sallovitz J, Lanusse C. Modulation of the P-glycoprotein-mediated intestinal secretion of ivermectin: in vitro and in vivo assessments. Drug Metab Dispos. 2006;34(3):457\u201363.","journal-title":"Drug Metab Dispos"},{"issue":"1\u20132","key":"1616_CR42","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijpharm.2010.10.017","volume":"403","author":"M Li","year":"2011","unstructured":"Li M, Si LQ, Pan HP, Rabba AK, Yan F, Qiu J, et al. Excipients enhance intestinal absorption of ganciclovir by P-gp inhibition: assessed in vitro by everted gut sac and in situ by improved intestinal perfusion. Int J Pharm. 2011;403(1\u20132):37\u201345.","journal-title":"Int J Pharm"},{"key":"1616_CR43","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijpharm.2019.04.033","volume":"564","author":"K Ueda","year":"2019","unstructured":"Ueda K, Iwai T, Sunazuka Y, Chen Z, Kato N, Higashi K, et al. Effect of molecular weight of hypromellose on mucin diffusion and oral absorption behavior of fenofibrate nanocrystal. Int J Pharm. 2019;564:39\u201347.","journal-title":"Int J Pharm"},{"issue":"26","key":"1616_CR44","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.1016\/j.biomaterials.2011.03.056","volume":"32","author":"T Yeh","year":"2011","unstructured":"Yeh T, Hsu L, Tseng M, Lee P, Sonjae K, Ho Y, et al. Mechanism and consequence of chitosan-mediated reversible epithelial tight junction opening. Biomaterials. 2011;32(26):6164\u201373.","journal-title":"Biomaterials"},{"key":"1616_CR45","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.actbio.2015.08.005","volume":"26","author":"S Sharma","year":"2015","unstructured":"Sharma S, Verma A, Pandey G, Mittapelly N, Mishra PR. Investigating the role of Pluronic-g-cationic polyelectrolyte as functional stabilizer for nanocrystals: impact on paclitaxel oral bioavailability and tumor growth. Acta Biomater. 2015;26:169\u201383.","journal-title":"Acta Biomater"},{"issue":"20","key":"1616_CR46","doi-asserted-by":"crossref","first-page":"12620","DOI":"10.1021\/acsami.6b01680","volume":"8","author":"X Miao","year":"2016","unstructured":"Miao X, Li Y, Wang X, Lee S, Zheng Y. Transport mechanism of coumarin 6 nanocrystals with two particle sizes in MDCKII monolayer and larval zebrafish. ACS Appl Mater Interfaces. 2016;8(20):12620\u201330.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"1","key":"1616_CR47","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1208\/s12249-011-9750-7","volume":"13","author":"DD Liu","year":"2012","unstructured":"Liu DD, Xu HM, Tian BC, Yuan K, Pan H, Ma SL, et al. Fabrication of carvedilol nanosuspensions through the anti-solvent precipitation\u2013ultrasonication method for the improvement of dissolution rate and oral bioavailability. AAPS PharmSciTech. 2012;13(1):295\u201304.","journal-title":"AAPS PharmSciTech"},{"issue":"7","key":"1616_CR48","doi-asserted-by":"crossref","first-page":"5803","DOI":"10.1021\/acsami.6b15151","volume":"9","author":"FY Deng","year":"2017","unstructured":"Deng FY, Zhang H, Wang X, Zhang Y, Hu HX, Song SY, et al. Transmembrane pathways and mechanisms of rod-like paclitaxel nanocrystals through MDCK polarized monolayer. ACS Appl Mater Interfaces. 2017;9(7):5803\u201316.","journal-title":"ACS Appl Mater Interfaces"},{"key":"1616_CR49","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jconrel.2019.06.015","volume":"307","author":"MR Guo","year":"2019","unstructured":"Guo MR, Wei MD, Li W, Guo MC, Guo CL, Ma MC, et al. Impacts of particle shapes on the oral delivery of drug nanocrystals: mucus permeation, transepithelial transport and bioavailability. J Control Release. 2019;307:64\u201375.","journal-title":"J Control Release"},{"key":"1616_CR50","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jconrel.2017.11.046","volume":"270","author":"YK Xie","year":"2017","unstructured":"Xie YK, Shi BK, Xia F, Qi JP, Dong XC, Zhao WL, et al. Epithelia transmembrane transport of orally administered ultrafine drug particles evidenced by environment sensitive fluorophores in cellular and animal studies. J Control Release. 2017;270:65\u201375.","journal-title":"J Control Release"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-019-1616-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12249-019-1616-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-019-1616-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T19:10:09Z","timestamp":1613070609000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12249-019-1616-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,13]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["1616"],"URL":"https:\/\/doi.org\/10.1208\/s12249-019-1616-4","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,13]]},"assertion":[{"value":"4 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"All procedures were approved by the Animal Research Ethics Committee, Jiangxi University of Traditional Chinese Medicine.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Statement"}},{"value":"The authors declare there are no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"90"}}